evenfolioETF Details
Tema ETFs·Health·HRTS · Nasdaq
Tema Heart & Health ETF (HRTS)
- Price
- $38.87
- —30 Oct 2026
- Assets
- $53.7M
- Total net assets
- Expense ratio
- 0.75%
- Category 1.00%
- Yield
- 1.30%
- Trailing distributions
- 1Y return
- 21.2%-7.6%
- Category 28.8%
- 3Y CAGR
- —
- Category 21.5%
- 5Y CAGR
- —
- Category 4.1%
Loading NAV history…
Tema Heart & Health ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +7.0% | +6.7% | +15.9% | +10.2% | +21.2% | — | — | — | +14.8% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | +3.4% | -3.2% | -7.1% | -10.3% | -7.6% | — | — | — | +3.2% |
Holdings
The 10 largest positions make up 48.2% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| LLY | Eli Lilly and Co | 11.45% |
| TMO | Thermo Fisher Scientific Inc | 5.77% |
| UNH | UnitedHealth Group Inc | 4.64% |
| MRK | Merck & Co Inc | 4.37% |
| NOVO-B.CO | Novo Nordisk AS Class B | 4.16% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 3.78% |
| RHHBY | Roche Holding AG ADR | 3.74% |
| JNJ | Johnson & Johnson | 3.67% |
| CYTK | Cytokinetics Inc | 3.37% |
| GILD | Gilead Sciences Inc | 3.28% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 26.4
- P/B
- 5.7
- P/S
- 2.7
- P/CF
- 17.8
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.6%
- Cash0.4%
ETF details
- Issuer
- Tema ETFs
- Category
- Equity · Health
- Ticker
- HRTS
- Exchange
- Nasdaq
- Inception
- 20 Nov 2023 (2.9 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.75% (category 1.00%)
- Holdings turnover
- 40% (category 51%)
- Distribution yield
- 1.30%
- Beta, 3 years
- 0.00
- Total net assets
- $53.7M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- FMED · Fidelity Disruptive Medicine ETFFidelity Investments · $52.3M · ER 0.50%
- BBC · Virtus Biotech Clinical Trials ETFVirtus · $43.8M · ER 0.65%5Y 0.0%
- MEDI · Harbor Health Care ETFHarbor Capital Advisors Inc · $41.7M · ER 0.80%
- HELX · Franklin Genomic Advancements ETFFranklin Templeton, Inc · $33.4M · ER 0.50%5Y -3.1%
- TMED · T. Rowe Price Health Care ETFT. Rowe Price · $33M · ER 0.44%
- HEAL · Global X HealthTech ETFGlobal X Funds · $31M · ER 0.50%5Y -10.9%